Year 2000 progress in Singapore and Thailand:
This article was originally published in Clinica
Executive Summary
Every public and private healthcare facility in Singapore, including hospitals, clinics and laboratories, is expected to have completed all Year 2000 compliance checks by the end of next month, according to the Straits Times. One of the island's leading hospitals, Tan Tock Seng, for example, has already tested its more than 800 items of life-support equipment to ensure they will continue to function when the date changes. In Thailand, the government has set up a Co-ordinating Committee for Y2K Problems, says the Bangkok Post. Government agencies are more than 90% Y2K-compliant already, although some problems could occur with hospital ultrasound equipment, the committee believes.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.